1. Home
  2. SON vs ALKS Comparison

SON vs ALKS Comparison

Compare SON & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonoco Products Company

SON

Sonoco Products Company

HOLD

Current Price

$49.56

Market Cap

4.9B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$36.82

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SON
ALKS
Founded
1899
1987
Country
United States
Ireland
Employees
N/A
2050
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
6.1B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
SON
ALKS
Price
$49.56
$36.82
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$60.13
$43.43
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
4.39%
N/A
EPS Growth
510.30
N/A
EPS
0.68
N/A
Revenue
$7,518,753,000.00
$1,475,899,000.00
Revenue This Year
$0.10
$24.26
Revenue Next Year
$1.82
$4.47
P/E Ratio
$71.64
N/A
Revenue Growth
41.72
N/A
52 Week Low
$38.65
$25.17
52 Week High
$58.44
$39.56

Technical Indicators

Market Signals
Indicator
SON
ALKS
Relative Strength Index (RSI) 46.93 58.04
Support Level $46.73 $27.65
Resistance Level $52.71 $39.56
Average True Range (ATR) 1.32 1.33
MACD -0.02 -0.08
Stochastic Oscillator 52.57 49.36

Price Performance

Historical Comparison
SON
ALKS

About SON Sonoco Products Company

Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: